Amended IN Assembly May 18, 2023 Amended IN Assembly May 02, 2023 Amended IN Assembly March 09, 2023 Amended IN Assembly March 02, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 33Introduced by Assembly Member Bains(Coauthors: Assembly Members Bryan, Joe Patterson, Waldron, Wood, and Zbur)December 05, 2022 An act to add and repeal Section 11455 of the Health and Safety Code, relating to controlled substances.LEGISLATIVE COUNSEL'S DIGESTAB 33, as amended, Bains. Fentanyl Addiction and Overdose Prevention Task Force.Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision.This bill would would, subject to an appropriation, establish the Fentanyl Addiction and Overdose Prevention Task Force to undertake various duties relating to fentanyl abuse, including, among others, collecting and organizing data on the nature and extent of fentanyl abuse in California and evaluating approaches to increase public awareness of fentanyl abuse. The bill would require the task force to be cochaired by the Attorney General and the Surgeon General, or their designees, and would specify the membership of the task force. TheThe bill would require the first meeting of the task force to take place no later than March 1, 2024, and would require the task force to meet at least once every 2 months. The bill would require the task force to submit an interim report to the Governor and the Legislature by January 1, 2025, and would require the task force to report its findings and recommendations to the Governor and the Legislature by July 1, 2025. TheThe bill would repeal these provisions on January 1, 2026.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 11455 is added to the Health and Safety Code, to read:11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
Amended IN Assembly May 18, 2023 Amended IN Assembly May 02, 2023 Amended IN Assembly March 09, 2023 Amended IN Assembly March 02, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 33Introduced by Assembly Member Bains(Coauthors: Assembly Members Bryan, Joe Patterson, Waldron, Wood, and Zbur)December 05, 2022 An act to add and repeal Section 11455 of the Health and Safety Code, relating to controlled substances.LEGISLATIVE COUNSEL'S DIGESTAB 33, as amended, Bains. Fentanyl Addiction and Overdose Prevention Task Force.Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision.This bill would would, subject to an appropriation, establish the Fentanyl Addiction and Overdose Prevention Task Force to undertake various duties relating to fentanyl abuse, including, among others, collecting and organizing data on the nature and extent of fentanyl abuse in California and evaluating approaches to increase public awareness of fentanyl abuse. The bill would require the task force to be cochaired by the Attorney General and the Surgeon General, or their designees, and would specify the membership of the task force. TheThe bill would require the first meeting of the task force to take place no later than March 1, 2024, and would require the task force to meet at least once every 2 months. The bill would require the task force to submit an interim report to the Governor and the Legislature by January 1, 2025, and would require the task force to report its findings and recommendations to the Governor and the Legislature by July 1, 2025. TheThe bill would repeal these provisions on January 1, 2026.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
Amended IN Assembly May 18, 2023 Amended IN Assembly May 02, 2023 Amended IN Assembly March 09, 2023 Amended IN Assembly March 02, 2023
Amended IN Assembly May 18, 2023
Amended IN Assembly May 02, 2023
Amended IN Assembly March 09, 2023
Amended IN Assembly March 02, 2023
CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
Assembly Bill
No. 33
Introduced by Assembly Member Bains(Coauthors: Assembly Members Bryan, Joe Patterson, Waldron, Wood, and Zbur)December 05, 2022
Introduced by Assembly Member Bains(Coauthors: Assembly Members Bryan, Joe Patterson, Waldron, Wood, and Zbur)
December 05, 2022
An act to add and repeal Section 11455 of the Health and Safety Code, relating to controlled substances.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
AB 33, as amended, Bains. Fentanyl Addiction and Overdose Prevention Task Force.
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision.This bill would would, subject to an appropriation, establish the Fentanyl Addiction and Overdose Prevention Task Force to undertake various duties relating to fentanyl abuse, including, among others, collecting and organizing data on the nature and extent of fentanyl abuse in California and evaluating approaches to increase public awareness of fentanyl abuse. The bill would require the task force to be cochaired by the Attorney General and the Surgeon General, or their designees, and would specify the membership of the task force. TheThe bill would require the first meeting of the task force to take place no later than March 1, 2024, and would require the task force to meet at least once every 2 months. The bill would require the task force to submit an interim report to the Governor and the Legislature by January 1, 2025, and would require the task force to report its findings and recommendations to the Governor and the Legislature by July 1, 2025. TheThe bill would repeal these provisions on January 1, 2026.
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision.
This bill would would, subject to an appropriation, establish the Fentanyl Addiction and Overdose Prevention Task Force to undertake various duties relating to fentanyl abuse, including, among others, collecting and organizing data on the nature and extent of fentanyl abuse in California and evaluating approaches to increase public awareness of fentanyl abuse. The bill would require the task force to be cochaired by the Attorney General and the Surgeon General, or their designees, and would specify the membership of the task force. The
The bill would require the first meeting of the task force to take place no later than March 1, 2024, and would require the task force to meet at least once every 2 months. The bill would require the task force to submit an interim report to the Governor and the Legislature by January 1, 2025, and would require the task force to report its findings and recommendations to the Governor and the Legislature by July 1, 2025. The
The bill would repeal these provisions on January 1, 2026.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. Section 11455 is added to the Health and Safety Code, to read:11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. Section 11455 is added to the Health and Safety Code, to read:11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
SECTION 1. Section 11455 is added to the Health and Safety Code, to read:
### SECTION 1.
11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:(1) Collect and organize data on the nature and extent of fentanyl abuse in California.(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.(4) Evaluate approaches to increase public awareness of fentanyl abuse.(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:(1) The Attorney General.(2) The Surgeon General.(3)The Director of the State Department of Public Health.(3) The State Public Health Officer.(4) The Director of the State Department of Health Care Services.(5) The Director of the State Department of Social Services.(6)The Director of the California Health and Human Services Agency.(6) The Secretary of California Health and Human Services.(7) One Member of the Senate, appointed by the Senate Rules Committee.(8) One Member of the Assembly, appointed by the Speaker of the Assembly.(9) The Chairperson of the Judicial Council.(10) One representative from the California District Attorneys Association.(11) One representative from the California Public Defenders Association.(12) One representative from the State Department of Education.(13) One representative from the California Hospital Association.(14) One representative from the California Medical Association.(15) One representative from the County Health Executives Association of California.(16) One representative from the County Behavioral Health Directors Association. Association of California.(17) One representative from a local health department, appointed by the Governor.(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.(19) One representative from the California Society of Addiction Medicine who is a mental health professional.(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.(21) One representative from a federally qualified health center, appointed by the Governor.(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.(23) One representative from an organization that provides services to youths relating to substance abuse.(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.(h)(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.
11455. (a) There is hereby established the Fentanyl Addiction and Overdose Prevention Task Force to do the following, to the extent feasible:
(1) Collect and organize data on the nature and extent of fentanyl abuse in California.
(2) Identify and assess sources and drivers of legal and illicit fentanyl activity in California.
(3) Measure and evaluate the progress and effectiveness of the states education, prevention, treatment, and enforcement efforts in preventing fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, including the prosecution of persons engaged in the illegal manufacture, sale, and trafficking of fentanyl.
(4) Evaluate approaches to increase public awareness of fentanyl abuse.
(5) Analyze existing statutes for their adequacy in addressing fentanyl abuse and, if the analysis determines that those statutes are inadequate, recommend revisions to those statutes or the enactment of new statutes that specifically define and address fentanyl abuse.
(6) Consult with governmental and nongovernmental organizations in developing recommendations to strengthen state and local efforts to prevent fentanyl abuse and death from the intentional use of fentanyl or the unintentional use of illicit substances containing fentanyl, protect and assist persons who misuse fentanyl or other illicit substances that may contain fentanyl, develop policy recommendations on the implementation of evidence-based practices to reduce fentanyl overdoses, and prosecute individuals engaged in the illegal manufacture, sale, and trafficking of fentanyl.
(7) Develop model treatment protocols for medication-assisted treatment (MAT) of fentanyl addiction and abuse, including, but not limited to, the prescription of buprenorphine and other medications.
(8) Recommend strategies to increase the ability and willingness of the medical community to treat fentanyl addiction and abuse, including identifying barriers to accessing medical care, biases within the medical community against people who misuse fentanyl or other illicit substances that may contain fentanyl, and legal, regulatory, and practical hurdles in the delivery of MAT, behavioral therapy, and other medical strategies critical in the treatment of fentanyl addiction and abuse, which may include, but are not limited to, overdose prevention centers, fentanyl testing strip distribution, and access to overdose reversal treatment.
(9) Assess gaps in federal, state, and local resources to address fentanyl addiction and abuse.
(b) The task force shall be cochaired by the Attorney General and the Surgeon General or their designees. The Department of Justice and the Office of the Surgeon General shall provide staff and support for the task force, to the extent that resources are available.
(c) The members of the task force shall serve at the pleasure of the respective appointing authority. Reimbursement of necessary expenses may be provided at the discretion of the respective appointing authority or agency participating in the task force. The task force shall be comprised of the following representatives or their designees:
(1) The Attorney General.
(2) The Surgeon General.
(3)The Director of the State Department of Public Health.
(3) The State Public Health Officer.
(4) The Director of the State Department of Health Care Services.
(5) The Director of the State Department of Social Services.
(6)The Director of the California Health and Human Services Agency.
(6) The Secretary of California Health and Human Services.
(7) One Member of the Senate, appointed by the Senate Rules Committee.
(8) One Member of the Assembly, appointed by the Speaker of the Assembly.
(9) The Chairperson of the Judicial Council.
(10) One representative from the California District Attorneys Association.
(11) One representative from the California Public Defenders Association.
(12) One representative from the State Department of Education.
(13) One representative from the California Hospital Association.
(14) One representative from the California Medical Association.
(15) One representative from the County Health Executives Association of California.
(16) One representative from the County Behavioral Health Directors Association. Association of California.
(17) One representative from a local health department, appointed by the Governor.
(18) Three representatives of law enforcement, one selected by the California State Sheriffs Association, one selected by the California Police Chiefs Association, and one selected by the Department of the California Highway Patrol.
(19) One representative from the California Society of Addiction Medicine who is a mental health professional.
(20) One representative who is in recovery from fentanyl or opioid abuse, appointed by the Governor.
(21) One representative from a federally qualified health center, appointed by the Governor.
(22) One representative from an organization that provides services to homeless individuals, one representative from an organization that provides services to individuals with substance use disorders, and one representative from an organization that serves persons who misuse fentanyl or other illicit substances that may contain fentanyl, appointed by the Governor.
(23) One representative from an organization that provides services to youths relating to substance abuse.
(d) Whenever possible, members of the task force shall have experience providing services to persons who misuse fentanyl or other illicit substances that may contain fentanyl or have knowledge of fentanyl abuse issues.
(e) The task force shall meet at least once every two months. Subcommittees may be formed and meet as necessary. All meetings shall be open to the public. The first meeting of the task force shall be held no later than March 1, 2024.
(f) (1) On or before July 1, 2025, the task force shall report its findings and recommendations to the Governor and the Legislature. At the request of any member, the report may include minority findings and recommendations.
(2) On or before January 1, 2025, the task force shall submit an interim report to the Governor and the Legislature.
(3) A report to be submitted pursuant to this subdivision shall be submitted in compliance with Section 9795 of the Government Code.
(g) For the purposes of this section, fentanyl abuse means the use of fentanyl or products containing fentanyl in a manner or with a frequency manner, or with a frequency, that negatively impacts one or more areas of physical, mental, or emotional health.
(h) This section shall be implemented only to the extent that an appropriation is made by the Legislature for the purpose of this section.
(h)
(i) This section shall remain in effect only until January 1, 2026, and as of that date is repealed.